{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T06:50:23Z","timestamp":1791960623471,"version":"4.3.4"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"42","license":[{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172676, 82373217, 82030082, 82202959"],"award-info":[{"award-number":["82172676, 82373217, 82030082, 82202959"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,11,4]]},"DOI":"10.1038\/s41388-026-03966-8","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:27:08Z","timestamp":1788539228000},"page":"4564-4580","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ITGA5 promotes homologous recombination mediated radioresistance in esophageal squamous cell carcinoma by upregulating RAD51AP1 expression"],"prefix":"10.1038","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2827-1860","authenticated-orcid":false,"given":"Xinyi","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6190-879X","authenticated-orcid":false,"given":"Jiayi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6422-9704","authenticated-orcid":false,"given":"Jiao","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jupeng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengfu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0804-3972","authenticated-orcid":false,"given":"Baoqing","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6762-7997","authenticated-orcid":false,"given":"Dawei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,4]]},"reference":[{"key":"3966_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"3966_CR2","doi-asserted-by":"crossref","unstructured":"Sheikh M, Roshandel G, McCormack V, Malekzadeh R. Current status and future prospects for esophageal cancer. Cancers. 2023;15:765.","DOI":"10.3390\/cancers15030765"},{"key":"3966_CR3","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1053\/j.gastro.2022.05.054","volume":"163","author":"E Morgan","year":"2022","unstructured":"Morgan E, Soerjomataram I, Rumgay H, Coleman HG, Thrift AP, Vignat J, et al. The Global landscape of esophageal squamous cell carcinoma and esophageal adenocarcinoma incidence and mortality in 2020 and Projections to 2040: new estimates from GLOBOCAN 2020. Gastroenterology. 2022;163:649\u201358.e642.","journal-title":"Gastroenterology"},{"key":"3966_CR4","doi-asserted-by":"publisher","first-page":"3108","DOI":"10.1097\/CM9.0000000000003420","volume":"137","author":"L Qi","year":"2024","unstructured":"Qi L, Sun M, Liu W, Zhang X, Yu Y, Tian Z, et al. Global esophageal cancer epidemiology in 2022 and predictions for 2050: a comprehensive analysis and projections based on GLOBOCAN data. Chin Med J. 2024;137:3108\u201316.","journal-title":"Chin Med J"},{"key":"3966_CR5","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.6004\/jnccn.2019.7337","volume":"17","author":"RJ Kelly","year":"2019","unstructured":"Kelly RJ. Emerging multimodality approaches to treat localized esophageal cancer. J Natl Compr Canc Netw. 2019;17:1009\u201314.","journal-title":"J Natl Compr Canc Netw"},{"key":"3966_CR6","doi-asserted-by":"publisher","first-page":"e2239778","DOI":"10.1001\/jamanetworkopen.2022.39778","volume":"5","author":"F Ge","year":"2022","unstructured":"Ge F, Huo Z, Cai X, Hu Q, Chen W, Lin G, et al. Evaluation of clinical and safety outcomes of neoadjuvant immunotherapy combined with chemotherapy for patients with resectable esophageal cancer: a systematic review and meta-analysis. JAMA Netw Open. 2022;5:e2239778.","journal-title":"JAMA Netw Open"},{"key":"3966_CR7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12957-021-02458-1","volume":"20","author":"Y Ma","year":"2022","unstructured":"Ma Y, Yao X, Li Z, Chen J, Li W, Wang H, et al. The role of vascular invasion and lymphatic invasion in predicting recurrent thoracic oesophageal squamous cell carcinoma. World J Surg Oncol. 2022;20:12.","journal-title":"World J Surg Oncol"},{"key":"3966_CR8","doi-asserted-by":"publisher","first-page":"e074962","DOI":"10.1136\/bmj-2023-074962","volume":"385","author":"N Deboever","year":"2024","unstructured":"Deboever N, Jones CM, Yamashita K, Ajani JA, Hofstetter WL. Advances in diagnosis and management of cancer of the esophagus. Bmj. 2024;385:e074962.","journal-title":"Bmj"},{"key":"3966_CR9","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/s41571-023-00757-y","volume":"20","author":"MA Shah","year":"2023","unstructured":"Shah MA, Altorki N, Patel P, Harrison S, Bass A, Abrams JA. Improving outcomes in patients with oesophageal cancer. Nat Rev Clin Oncol. 2023;20:390\u2013407.","journal-title":"Nat Rev Clin Oncol"},{"key":"3966_CR10","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.suc.2021.03.006","volume":"101","author":"SX Wang","year":"2021","unstructured":"Wang SX, Marshall MB. Chemoradiation therapy as definitive treatment of esophageal cancer. Surg Clin North Am. 2021;101:443\u201351.","journal-title":"Surg Clin North Am"},{"key":"3966_CR11","doi-asserted-by":"publisher","first-page":"4926","DOI":"10.1158\/0008-5472.CAN-21-0653","volume":"81","author":"H Hirata","year":"2021","unstructured":"Hirata H, Niida A, Kakiuchi N, Uchi R, Sugimachi K, Masuda T, et al. The evolving genomic landscape of esophageal squamous cell carcinoma under chemoradiotherapy. Cancer Res. 2021;81:4926\u201338.","journal-title":"Cancer Res"},{"key":"3966_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01801-2","volume":"22","author":"Y Wu","year":"2023","unstructured":"Wu Y, Song Y, Wang R, Wang T. Molecular mechanisms of tumor resistance to radiotherapy. Mol Cancer. 2023;22:96.","journal-title":"Mol Cancer"},{"key":"3966_CR13","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41392-020-0150-x","volume":"5","author":"RX Huang","year":"2020","unstructured":"Huang RX, Zhou PK. DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer. Signal Transduct Target Ther. 2020;5:60.","journal-title":"Signal Transduct Target Ther"},{"key":"3966_CR14","doi-asserted-by":"publisher","first-page":"10502","DOI":"10.1074\/jbc.TM118.000371","volume":"293","author":"J Her","year":"2018","unstructured":"Her J, Bunting SF. How cells ensure correct repair of DNA double-strand breaks. J Biol Chem. 2018;293:10502\u201311.","journal-title":"J Biol Chem"},{"key":"3966_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2022.100049","volume":"36","author":"KD Doig","year":"2023","unstructured":"Doig KD, Fellowes AP, Fox SB. Homologous recombination repair deficiency: an overview for pathologists. Mod Pathol. 2023;36:100049.","journal-title":"Mod Pathol"},{"key":"3966_CR16","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.dnarep.2017.09.008","volume":"59","author":"E Pires","year":"2017","unstructured":"Pires E, Sung P, Wiese C. Role of RAD51AP1 in homologous recombination DNA repair and carcinogenesis. DNA Repair. 2017;59:76\u201381.","journal-title":"DNA Repair"},{"key":"3966_CR17","doi-asserted-by":"publisher","first-page":"4946","DOI":"10.1093\/nar\/25.24.4946","volume":"25","author":"OV Kovalenko","year":"1997","unstructured":"Kovalenko OV, Golub EI, Bray-Ward P, Ward DC, Radding CM. A novel nucleic acid-binding protein that interacts with human rad51 recombinase. Nucleic Acids Res. 1997;25:4946\u201353.","journal-title":"Nucleic Acids Res"},{"key":"3966_CR18","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1158\/1078-0432.CCR-07-1381","volume":"14","author":"K Obama","year":"2008","unstructured":"Obama K, Satoh S, Hamamoto R, Sakai Y, Nakamura Y, Furukawa Y. Enhanced expression of RAD51 associating protein-1 is involved in the growth of intrahepatic cholangiocarcinoma cells. Clin Cancer Res. 2008;14:1333\u20139.","journal-title":"Clin Cancer Res"},{"key":"3966_CR19","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3748\/wjg.v10.i4.509","volume":"10","author":"H Song","year":"2004","unstructured":"Song H, Xia SL, Liao C, Li YL, Wang YF, Li TP, et al. Genes encoding Pir51, Beclin 1, RbAp48 and aldolase b are up or down-regulated in human primary hepatocellular carcinoma. World J Gastroenterol. 2004;10:509\u201313.","journal-title":"World J Gastroenterol"},{"key":"3966_CR20","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/sj.onc.1210700","volume":"27","author":"A Kauffmann","year":"2008","unstructured":"Kauffmann A, Rosselli F, Lazar V, Winnepenninckx V, Mansuet-Lupo A, Dessen P, et al. High expression of DNA repair pathways is associated with metastasis in melanoma patients. Oncogene. 2008;27:565\u201373.","journal-title":"Oncogene"},{"key":"3966_CR21","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1158\/0008-5472.CAN-15-2249","volume":"76","author":"R Pathania","year":"2016","unstructured":"Pathania R, Ramachandran S, Mariappan G, Thakur P, Shi H, Choi JH, et al. Combined Inhibition of DNMT and HDAC Blocks the Tumorigenicity of Cancer Stem-like Cells and Attenuates Mammary Tumor Growth. Cancer Res. 2016;76:3224\u201335.","journal-title":"Cancer Res"},{"key":"3966_CR22","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nrm.2017.48","volume":"18","author":"HHY Chang","year":"2017","unstructured":"Chang HHY, Pannunzio NR, Adachi N, Lieber MR. Non-homologous DNA end joining and alternative pathways to double-strand break repair. Nat Rev Mol Cell Biol. 2017;18:495\u2013506.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3966_CR23","doi-asserted-by":"crossref","unstructured":"Campbell ID, Humphries MJ. Integrin structure, activation, and interactions. Cold Spring Harb Perspect Biol. 2011;3:a004994 .","DOI":"10.1101\/cshperspect.a004994"},{"key":"3966_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2023.108458","volume":"247","author":"F Liu","year":"2023","unstructured":"Liu F, Wu Q, Dong Z, Liu K. Integrins in cancer: emerging mechanisms and therapeutic opportunities. Pharmacol Ther. 2023;247:108458.","journal-title":"Pharmacol Ther"},{"key":"3966_CR25","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ccell.2019.01.007","volume":"35","author":"J Cooper","year":"2019","unstructured":"Cooper J, Giancotti FG. Integrin signaling in cancer: mechanotransduction, stemness, epithelial plasticity, and therapeutic resistance. Cancer Cell. 2019;35:347\u201367.","journal-title":"Cancer Cell"},{"key":"3966_CR26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3390\/cancers5010027","volume":"5","author":"F Schaffner","year":"2013","unstructured":"Schaffner F, Ray AM, Dontenwill M. Integrin \u03b15\u03b21, the fibronectin receptor, as a pertinent therapeutic target in solid tumors. Cancers. 2013;5:27\u201347.","journal-title":"Cancers"},{"key":"3966_CR27","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s41556-018-0223-z","volume":"21","author":"P Moreno-Layseca","year":"2019","unstructured":"Moreno-Layseca P, Icha J, Hamidi H, Ivaska J. Integrin trafficking in cells and tissues. Nat Cell Biol. 2019;21:122\u201332.","journal-title":"Nat Cell Biol"},{"key":"3966_CR28","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1126\/science.285.5430.1028","volume":"285","author":"FG Giancotti","year":"1999","unstructured":"Giancotti FG, Ruoslahti E. Integrin signaling. Science. 1999;285:1028\u201332.","journal-title":"Science"},{"key":"3966_CR29","doi-asserted-by":"publisher","first-page":"13329","DOI":"10.2147\/OTT.S273803","volume":"13","author":"J Hou","year":"2020","unstructured":"Hou J, Yan D, Liu Y, Huang P, Cui H. The roles of integrin \u03b15\u03b21 in human cancer. Onco Targets Ther. 2020;13:13329\u201344.","journal-title":"Onco Targets Ther"},{"key":"3966_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-01944-w","volume":"23","author":"C Zhang","year":"2024","unstructured":"Zhang C, Yu Z, Yang S, Liu Y, Song J, Mao J, et al. ZNF460-mediated circRPPH1 promotes TNBC progression through ITGA5-induced FAK\/PI3K\/AKT activation in a ceRNA manner. Mol Cancer. 2024;23:33.","journal-title":"Mol Cancer"},{"key":"3966_CR31","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/8611306","volume":"2022","author":"JF Wang","year":"2022","unstructured":"Wang JF, Chen YY, Zhang SW, Zhao K, Qiu Y, Wang Y, et al. ITGA5 promotes tumor progression through the activation of the FAK\/AKT signaling pathway in human gastric cancer. Oxid Med Cell Longev. 2022;2022:8611306.","journal-title":"Oxid Med Cell Longev"},{"key":"3966_CR32","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1186\/s13046-019-1376-8","volume":"38","author":"J Chen","year":"2019","unstructured":"Chen J, Chen T, Zhu Y, Li Y, Zhang Y, Wang Y, et al. circPTN sponges miR-145-5p\/miR-330-5p to promote proliferation and stemness in glioma. J Exp Clin Cancer Res. 2019;38:398.","journal-title":"J Exp Clin Cancer Res"},{"key":"3966_CR33","doi-asserted-by":"publisher","first-page":"11983","DOI":"10.1002\/cam4.5873","volume":"12","author":"X Xu","year":"2023","unstructured":"Xu X, Shen L, Li W, Liu X, Yang P, Cai J. ITGA5 promotes tumor angiogenesis in cervical cancer. Cancer Med. 2023;12:11983\u201399.","journal-title":"Cancer Med"},{"key":"3966_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06843-y","volume":"15","author":"H Lu","year":"2024","unstructured":"Lu H, Ai J, Zheng Y, Zhou W, Zhang L, Zhu J, et al. IGFBP2\/ITGA5 promotes gefitinib resistance via activating STAT3\/CXCL1 axis in non-small cell lung cancer. Cell Death Dis. 2024;15:447.","journal-title":"Cell Death Dis"},{"key":"3966_CR35","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abf6290","volume":"7","author":"Y Yang","year":"2021","unstructured":"Yang Y, Wu M, Cao D, Yang C, Jin J, Wu L, et al. ZBP1-MLKL necroptotic signaling potentiates radiation-induced antitumor immunity via intratumoral STING pathway activation. Sci Adv. 2021;7:eabf6290.","journal-title":"Sci Adv"},{"key":"3966_CR36","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.ijrobp.2016.01.064","volume":"95","author":"C Song","year":"2016","unstructured":"Song C, Hong BJ, Bok S, Lee CJ, Kim YE, Jeon SR, et al. Real-time tumor oxygenation changes after single high-dose radiation therapy in orthotopic and subcutaneous lung cancer in mice: clinical implication for stereotactic ablative radiation therapy schedule optimization. Int J Radiat Oncol Biol Phys. 2016;95:1022\u201331.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3966_CR37","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/1756-9966-31-78","volume":"31","author":"L Bobyk","year":"2012","unstructured":"Bobyk L, Edouard M, Deman P, Rousseau J, Adam JF, Ravanat JL, et al. Intracerebral delivery of carboplatin in combination with either 6 MV photons or monoenergetic synchrotron X-rays are equally efficacious for treatment of the F98 rat glioma. J Exp Clin Cancer Res. 2012;31:78.","journal-title":"J Exp Clin Cancer Res"},{"key":"3966_CR38","doi-asserted-by":"publisher","first-page":"10290","DOI":"10.1073\/pnas.0904227106","volume":"106","author":"T Shibue","year":"2009","unstructured":"Shibue T, Weinberg RA. Integrin beta1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs. Proc Natl Acad Sci USA. 2009;106:10290\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3966_CR39","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.semcancer.2014.07.009","volume":"31","author":"I Eke","year":"2015","unstructured":"Eke I, Cordes N. Focal adhesion signaling and therapy resistance in cancer. Semin Cancer Biol. 2015;31:65\u201375.","journal-title":"Semin Cancer Biol"},{"key":"3966_CR40","doi-asserted-by":"publisher","first-page":"D102","DOI":"10.2741\/Cary","volume":"4","author":"LA Cary","year":"1999","unstructured":"Cary LA, Guan JL. Focal adhesion kinase in integrin-mediated signaling. Front Biosci. 1999;4:D102\u2013113.","journal-title":"Front Biosci"},{"key":"3966_CR41","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.addr.2010.11.001","volume":"63","author":"X Zhao","year":"2011","unstructured":"Zhao X, Guan JL. Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis. Adv Drug Deliv Rev. 2011;63:610\u20135.","journal-title":"Adv Drug Deliv Rev"},{"key":"3966_CR42","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1056\/NEJMra1608986","volume":"377","author":"DE Citrin","year":"2017","unstructured":"Citrin DE. Recent developments in radiotherapy. N Engl J Med. 2017;377:1065\u201375.","journal-title":"N Engl J Med"},{"key":"3966_CR43","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/nrd4003","volume":"12","author":"EJ Moding","year":"2013","unstructured":"Moding EJ, Kastan MB, Kirsch DG. Strategies for optimizing the response of cancer and normal tissues to radiation. Nat Rev Drug Discov. 2013;12:526\u201342.","journal-title":"Nat Rev Drug Discov"},{"key":"3966_CR44","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S0092-8674(02)00971-6","volume":"110","author":"RO Hynes","year":"2002","unstructured":"Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell. 2002;110:673\u201387.","journal-title":"Cell"},{"key":"3966_CR45","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrc2748","volume":"10","author":"JS Desgrosellier","year":"2010","unstructured":"Desgrosellier JS, Cheresh DA. Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer. 2010;10:9\u201322.","journal-title":"Nat Rev Cancer"},{"key":"3966_CR46","doi-asserted-by":"publisher","first-page":"7431","DOI":"10.7150\/thno.76232","volume":"12","author":"D Li","year":"2022","unstructured":"Li D, Sun A, Zhang L, Ding Z, Yi F, Yang X, et al. Elevated ITGA5 facilitates hyperactivated mTORC1-mediated progression of laryngeal squamous cell carcinoma via upregulation of EFNB2. Theranostics. 2022;12:7431\u201349.","journal-title":"Theranostics"},{"key":"3966_CR47","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.7150\/ijbs.66184","volume":"18","author":"X Zhang","year":"2022","unstructured":"Zhang X, Chen F, Huang P, Wang X, Zhou K, Zhou C, et al. Exosome-depleted MiR-148a-3p derived from hepatic stellate cells promotes tumor progression via ITGA5\/PI3K\/Akt Axis in Hepatocellular Carcinoma. Int J Biol Sci. 2022;18:2249\u201360.","journal-title":"Int J Biol Sci"},{"key":"3966_CR48","doi-asserted-by":"crossref","unstructured":"Pachane BC, Selistre-de-Araujo HS. The role of \u03b1v\u03b23 integrin in cancer therapy resistance. Biomedicines. 2024;12:1163.","DOI":"10.3390\/biomedicines12061163"},{"key":"3966_CR49","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.tcb.2014.12.006","volume":"25","author":"L Seguin","year":"2015","unstructured":"Seguin L, Desgrosellier JS, Weis SM, Cheresh DA. Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance. Trends Cell Biol. 2015;25:234\u201340.","journal-title":"Trends Cell Biol"},{"key":"3966_CR50","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1158\/0008-5472.CAN-13-1742","volume":"74","author":"A Jahangiri","year":"2014","unstructured":"Jahangiri A, Aghi MK, Carbonell WS. \u03b21 integrin: critical path to antiangiogenic therapy resistance and beyond. Cancer Res. 2014;74:3\u20137.","journal-title":"Cancer Res"},{"key":"3966_CR51","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/nrc3007","volume":"11","author":"AC Begg","year":"2011","unstructured":"Begg AC, Stewart FA, Vens C. Strategies to improve radiotherapy with targeted drugs. Nat Rev Cancer. 2011;11:239\u201353.","journal-title":"Nat Rev Cancer"},{"key":"3966_CR52","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nrc3958","volume":"15","author":"HE Barker","year":"2015","unstructured":"Barker HE, Paget JT, Khan AA, Harrington KJ. The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence. Nat Rev Cancer. 2015;15:409\u201325.","journal-title":"Nat Rev Cancer"},{"key":"3966_CR53","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nrc2419","volume":"8","author":"M Baumann","year":"2008","unstructured":"Baumann M, Krause M, Hill R. Exploring the role of cancer stem cells in radioresistance. Nat Rev Cancer. 2008;8:545\u201354.","journal-title":"Nat Rev Cancer"},{"key":"3966_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216108","volume":"559","author":"J Peng","year":"2023","unstructured":"Peng J, Yin X, Yun W, Meng X, Huang Z. Radiotherapy-induced tumor physical microenvironment remodeling to overcome immunotherapy resistance. Cancer Lett. 2023;559:216108.","journal-title":"Cancer Lett"},{"key":"3966_CR55","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nrc.2015.4","volume":"16","author":"PA Jeggo","year":"2016","unstructured":"Jeggo PA, Pearl LH, Carr AM. DNA repair, genome stability and cancer: a historical perspective. Nat Rev Cancer. 2016;16:35\u201342.","journal-title":"Nat Rev Cancer"},{"key":"3966_CR56","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41392-021-00648-7","volume":"6","author":"R Huang","year":"2021","unstructured":"Huang R, Zhou PK. DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy. Signal Transduct Target Ther. 2021;6:254.","journal-title":"Signal Transduct Target Ther"},{"key":"3966_CR57","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/nature08467","volume":"461","author":"SP Jackson","year":"2009","unstructured":"Jackson SP, Bartek J. The DNA-damage response in human biology and disease. Nature. 2009;461:1071\u20138.","journal-title":"Nature"},{"key":"3966_CR58","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1146\/annurev.biochem.052308.093131","volume":"79","author":"MR Lieber","year":"2010","unstructured":"Lieber MR. The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. Annu Rev Biochem. 2010;79:181\u2013211.","journal-title":"Annu Rev Biochem"},{"key":"3966_CR59","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/nrm2008","volume":"7","author":"P Sung","year":"2006","unstructured":"Sung P, Klein H. Mechanism of homologous recombination: mediators and helicases take on regulatory functions. Nat Rev Mol Cell Biol. 2006;7:739\u201350.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3966_CR60","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1146\/annurev-genet-051710-150955","volume":"44","author":"WD Heyer","year":"2010","unstructured":"Heyer WD, Ehmsen KT, Liu J. Regulation of homologous recombination in eukaryotes. Annu Rev Genet. 2010;44:113\u201339.","journal-title":"Annu Rev Genet"},{"key":"3966_CR61","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/cr.2008.1","volume":"18","author":"X Li","year":"2008","unstructured":"Li X, Heyer WD. Homologous recombination in DNA repair and DNA damage tolerance. Cell Res. 2008;18:99\u2013113.","journal-title":"Cell Res"},{"key":"3966_CR62","first-page":"130","volume":"2","author":"AJ Davis","year":"2013","unstructured":"Davis AJ, Chen DJ. DNA double strand break repair via non-homologous end-joining. Transl Cancer Res. 2013;2:130\u201343.","journal-title":"Transl Cancer Res"},{"key":"3966_CR63","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/s41580-020-00297-8","volume":"21","author":"B Zhao","year":"2020","unstructured":"Zhao B, Rothenberg E, Ramsden DA, Lieber MR. The molecular basis and disease relevance of non-homologous DNA end joining. Nat Rev Mol Cell Biol. 2020;21:765\u201381.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3966_CR64","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.clon.2014.02.004","volume":"26","author":"A Shibata","year":"2014","unstructured":"Shibata A, Jeggo PA. DNA double-strand break repair in a cellular context. Clin Oncol. 2014;26:243\u20139.","journal-title":"Clin Oncol"},{"key":"3966_CR65","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.molcel.2012.07.029","volume":"47","author":"JR Chapman","year":"2012","unstructured":"Chapman JR, Taylor MR, Boulton SJ. Playing the end game: DNA double-strand break repair pathway choice. Mol Cell. 2012;47:497\u2013510.","journal-title":"Mol Cell"},{"key":"3966_CR66","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1242\/jcs.112.16.2677","volume":"112","author":"DJ Sieg","year":"1999","unstructured":"Sieg DJ, Hauck CR, Schlaepfer DD. Required role of focal adhesion kinase (FAK) for integrin-stimulated cell migration. J Cell Sci. 1999;112:2677\u201391.","journal-title":"J Cell Sci"},{"key":"3966_CR67","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0945-053X(97)90008-1","volume":"16","author":"JL Guan","year":"1997","unstructured":"Guan JL. Focal adhesion kinase in integrin signaling. Matrix Biol. 1997;16:195\u2013200.","journal-title":"Matrix Biol"},{"key":"3966_CR68","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/nrg1879","volume":"7","author":"JA Engelman","year":"2006","unstructured":"Engelman JA, Luo J, Cantley LC. The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet. 2006;7:606\u201319.","journal-title":"Nat Rev Genet"},{"key":"3966_CR69","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/imm.13838","volume":"173","author":"S Zheng","year":"2024","unstructured":"Zheng S, He S, Liang Y, Liu Q, Liu T, Tan Y, et al. NME4 suppresses NF\u03baB2-CCL5 axis, restricting CD8+ T cell tumour infiltration in oesophageal squamous cell carcinoma. Immunology. 2024;173:408\u201321.","journal-title":"Immunology"},{"key":"3966_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2024.119781","volume":"1871","author":"Y Liang","year":"2024","unstructured":"Liang Y, He S, Liu Q, Liu T, Tan Y, Peng T, et al. Vimentin, inversely correlating with infiltration of CD8 + T lymphocytes, promotes nuclear translocation of PD-L1 in esophageal squamous cell carcinoma. Biochim Biophys Acta Mol Cell Res. 2024;1871:119781.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"3966_CR71","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1016\/j.celrep.2016.05.007","volume":"15","author":"F Liang","year":"2016","unstructured":"Liang F, Longerich S, Miller AS, Tang C, Buzovetsky O, Xiong Y, et al. Promotion of RAD51-mediated homologous DNA pairing by the RAD51AP1-UAF1 complex. Cell Rep. 2016;15:2118\u201326.","journal-title":"Cell Rep"},{"key":"3966_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.100844","volume":"297","author":"E Pires","year":"2021","unstructured":"Pires E, Sharma N, Selemenakis P, Wu B, Huang Y, Alimbetov DS, et al. RAD51AP1 mediates RAD51 activity through nucleosome interaction. J Biol Chem. 2021;297:100844.","journal-title":"J Biol Chem"},{"key":"3966_CR73","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.866601","volume":"10","author":"P Selemenakis","year":"2022","unstructured":"Selemenakis P, Sharma N, Uhrig ME, Katz J, Kwon Y, Sung P, et al. RAD51AP1 and RAD54L can underpin two distinct RAD51-dependent routes of DNA damage repair via homologous recombination. Front Cell Dev Biol. 2022;10:866601.","journal-title":"Front Cell Dev Biol"},{"key":"3966_CR74","doi-asserted-by":"publisher","first-page":"e0121396","DOI":"10.1371\/journal.pone.0121396","volume":"10","author":"P Sankaranarayanan","year":"2015","unstructured":"Sankaranarayanan P, Schomay TE, Aiello KA, Alter O. Tensor GSVD of patient- and platform-matched tumor and normal DNA copy-number profiles uncovers chromosome arm-wide patterns of tumor-exclusive platform-consistent alterations encoding for cell transformation and predicting ovarian cancer survival. PLoS ONE. 2015;10:e0121396.","journal-title":"PLoS ONE"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03966-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03966-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03966-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T06:38:34Z","timestamp":1791959914000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03966-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":74,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2026,11,4]]}},"alternative-id":["3966"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03966-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8195442\/v1","asserted-by":"object"}]},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,4]]},"assertion":[{"value":"24 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}